China Shineway Pharmaceutical Group (02877.HK) saw its stock price surge 5.39% in intraday trading on Wednesday, following the release of impressive first-half financial results and the declaration of an interim dividend.

The pharmaceutical company reported robust financial performance for the first half of 2025. Sales reached RMB 1,652.7 million, while net income stood at RMB 614.7 million. Notably, the company maintained a high gross margin of 72.2%, indicating strong profitability in its core operations.

Adding to investor enthusiasm, China Shineway Pharmaceutical also declared a second interim dividend of RMB 11 cents per share for 2025. This dividend announcement, coupled with the strong financial results, likely contributed to the significant uptick in the company's stock price during the trading session.